Clinical trial
A Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients With Major Depressive Disorder
NCT00107120 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients With Major Depressive Disorder
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- Not reported
- Enrollment
- 312 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.